Back to today’s briefing

Story perspectives

23andMe Faces Crisis: Sale Consideration Amid Data Breach

1/29/2025

41 7

Summary

Story summary

23andMe is at a crossroads, contemplating a potential sale amid financial turmoil and a devastating data breach. With its stock plummeting 96% since 2021 and an 8% drop in revenue, the company faces mounting pressure. Leadership instability and plans to slash 40% of its workforce only deepen the crisis, leaving its future uncertain.

1 of 1

Story summary

23andMe is at a crossroads, contemplating a potential sale amid financial turmoil and a devastating data breach. With its stock plummeting 96% since 2021 and an 8% drop in revenue, the company faces mounting pressure. Leadership instability and plans to slash 40% of its workforce only deepen the crisis, leaving its future uncertain.